Aldehyde Dehydrogenase Variants for Renewable Butanediol Biosynthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing commodity chemicals like 1,4-butanediol and 1,3-butanediol rely on petroleum-based sources, which are energy- and capital-intensive, and there is a need for renewable and less intensive production methods.

Innovation Solution

Engineering cells, such as microbial organisms, with aldehyde dehydrogenase variants to produce 3-hydroxybutyraldehyde, 1,3-butanediol, 4-hydroxybutyraldehyde, and 1,4-butanediol through metabolic pathways, utilizing engineered enzymes and genetic modifications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Use of energy by moving object

If petroleum-based sources are used to produce commodity chemicals, then production capacity is sufficient, but energy consumption and capital requirements are high

Engineering Contradiction:
Improveenergy consumptionVSAvoidproduction capacity
Core Design Contradiction:
Use of energy by moving objectVSProductivity

Solution Approach 1:

The patent changes the fundamental parameter of feedstock source from petroleum-based to renewable plant-based sources. This parameter change enables production with lower energy consumption and capital requirements while maintaining productivity through engineered metabolic pathways in microorganisms that efficiently convert renewable substrates into target chemicals

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces conventional chemical processing methods with biological systems. Engineered microorganisms perform the chemical transformations through metabolic pathways, substituting mechanical/chemical processing infrastructure with biological factories that operate under milder conditions with lower energy input

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Adaptability or versatility

If conventional production methods are used, then established processes are available, but renewable sources are not provided

Engineering Contradiction:
Improverenewable source capabilityVSAvoidprocess simplicity
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent segments the production process into distinct functional modules: substrate uptake systems, engineered metabolic pathways for intermediate conversion, and product synthesis pathways. This modular segmentation allows renewable sources to be integrated while maintaining process simplicity through standardized biological components that can be assembled and optimized independently

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent creates universal engineered microorganisms that can process multiple renewable substrates through programmable metabolic pathways. The same host organism and pathway design framework can be applied to produce different target chemicals from various plant-based feedstocks, providing versatility without increasing manufacturing complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Facilitates the production of enantiomerically pure and high-purity 1,3-butanediol, providing renewable sources for petroleum-based products with improved efficiency and reduced energy and capital requirements.

Implementation Method 1

aldehyde dehydrogenase variants... produce 3-hydroxybutyraldehyde... 4-hydroxybutyraldehyde

Methodology Applied
Scientific EffectDehydrogenation: Oxidation

Data Source

PatentUS20250382590A1Aldehyde dehydrogenase variants and methods of using same
Publication Date: 2025.12.18 GENOMATICA INC
  • US20250382590A1 patent drawing
  • US20250382590A1 patent drawing
  • US20250382590A1 patent drawing

AI summary

The invention provides polypeptides and encoding nucleic acids of aldehyde dehydrogenase variants. The invention also provides cells expressing aldehyde dehydrogenase variants. The invention further provides methods for producing 3-hydroxybutyraldehyde (3-HBal) and/or 1,3-butanediol (1,3-BDO), or an ester or amide thereof, comprising culturing cells expressing an aldehyde dehydrogenase variant or using lysates of such cells. The invention additional provides methods for producing 4-hydroxybutyraldehyde (4-HBal) and/or 1,4-butanediol (1,4-BDO), or an ester or amide thereof, comprising culturing cells expressing an aldehyde dehydrogenase variant or using lysates of such cells.